India to Myanmar: Ciprofloxacin Export Trade Route

The India to Myanmar Ciprofloxacin corridor is one of India's established pharmaceutical export routes, with 131 shipments documented worth a combined $3.5M USD. The route is dominated by LINCOLN PHARMACEUTICALS LTD, which alone accounts for roughly 48% of all export value, reflecting the consolidated nature of India's ciprofloxacin manufacturing sector.

Across 44 active suppliers, the average shipment value stands at $26.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with ciprofloxacin's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 24.1%, placing it at rank #8 among India's top ciprofloxacin export destinations globally.

On the import side, key buyers of Indian ciprofloxacin in Myanmar include UNIVERSAL CO. LTD., LEGEND CREATIVES CO. LTD., AORTA COMPANY LIMITED and 58 others. UNIVERSAL CO. LTD. is the single largest importer with 4 shipments valued at $1.7M USD.

India's ciprofloxacin exports to Myanmar are driven primarily by a handful of large-scale manufacturers. LINCOLN PHARMACEUTICALS LTD with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 44 active exporters signals a competitive but concentrated market — buyers in Myanmar benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — LINCOLN PHARMACEUTICALS LTD, MULTICO EXPORTS PRIVATE LIMITED, AMN LIFE PRIVATE LIMITED — together account for 74% of total trade value on this route. The average shipment value of $26.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as ciprofloxacin ophthalmic solution usp (u and ciprofloxacin tablets bp (proxic-250) (1, suggesting that buyers in Myanmar tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, UNIVERSAL CO. LTD. is the largest importer with 4 shipments worth $1.7M USD — representing 48% of all ciprofloxacin imports from India on this route. A total of 61 buyers are active on this corridor.